Bone Density Reduction: Tenofovir has long been related to a lessen in bone mineral density, expanding the chance of bone complications or fractures.HIV-one infected topics on dolutegravir monotherapy demonstrated immediate and dose-dependent reduction of antiviral activity with declines of HIV-one RNA copies for every ml. The antiviral response wa